Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAF1 | P04049 | 5/20 | 0.55 |
| ▸ | BRAF | P15056 | 5/20 | 0.55 |
| ▸ | MAPK14 | Q16539 | 15/20 | 0.51 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.51 |
| ▸ | MAPK12 | P53778 | 2/20 | 0.51 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.51 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14473262 | 0.95 | RAF1 (0.54) | RAF1BRAFMAPK14MAPK13MAPK12 | |
| SCHEMBL14473260 | 0.90 | RAF1 (0.53) | RAF1BRAFMAPK14MAPK13MAPK12 | |
| SCHEMBL4544150 | 0.89 | USP30 (0.44) | RAF1BRAFMAPK14MAPK13MAPK12 | |
| SCHEMBL4541538 | 0.88 | RAF1 (0.56) | RAF1BRAFMAPK14 | |
| SCHEMBL5593458 | 0.87 | BRAF (0.61) | RAF1BRAFMAPK14 | |
| SCHEMBL4566569 | 0.86 | RAF1 (0.55) | RAF1BRAFMAPK14MAPK13MAPK12 | |
| SCHEMBL14473261 | 0.86 | RAF1 (0.56) | RAF1BRAFMAPK14 | |
| SCHEMBL4412542 | 0.82 | RAF1 (0.54) | RAF1BRAFMAPK14MAPK13MAPK12 | |
| SCHEMBL4727827 | 0.79 | MAPK14 (0.56) | RAF1BRAFMAPK14MAPK13MAPK12 | |
| SCHEMBL5592994 | 0.78 | RAF1 (0.48) | RAF1BRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2035005-A2 | THERAPY USING CYTOKINE INHIBITORS | Kemia, INC. (US) | 2009-03-18 | — | — | EP | disclosed |
| WO-2007146712-A2 | THERAPY USING CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2007-12-21 | — | — | WO | disclosed |